U.S. Involvement In International IVD Standards Development Lags Europe
This article was originally published in The Gray Sheet
Executive Summary
Increased involvement by U.S. in vitro diagnostic manufacturers in international standards development would help avert adoption of additional "vertical" device-specific standards, according to Powers Consulting Services President Donald Powers, PhD.
You may also be interested in...
French Glucose Monitor Removal Order Carried Out Over Industry Opposition
A decision by the French government to implement its previously announced plan to remove from the market certain self-testing in vitro diagnostic blood glucose monitors apparently will not affect the offerings of Johnson & Johnson subsidiary LifeScan.
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.